Summary: ‘Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2023-24’

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.)
• Description:
  cdc:132249
• Content Notes:
  Groups Recommended for Vaccination -- Timing of Vaccination -- Approved Ages & Dose Volumes -- Influenza Vaccination in Pregnancy -- Number of Doses for Ages 6 Months through 8 Years -- Adults Aged ‚â•65 Years -- Vaccination of Persons with COVID-19 -- Persons with Chronic Medical Conditions -- Immunocompromised Persons -- Caregivers and Contacts of High-Risk Persons -- Persons with Egg Allergy -- Previous Severe Allergic Reactions to Influenza Vaccines -- Vaccination Issues for Travelers -- Vaccination and Influenza Antiviral Medications -- Administration of Influenza Vaccines with Other Vaccines -- Vaccine Adverse Event Reporting System (VAERS) -- Further Information -- Inactivated Influenza Vaccines (IIV4s) and Recombinant Influenza Vaccine (RIV4) -- Live Attenuated Influenza Vaccine (LAIV4) -- Influenza Vaccine Contraindications and Precautions -- Contraindications and Precautions for Persons with a History of Severe Allergic Reaction to an Influenza Vaccine
• Subjects:
  Antigens, Viral/immunology Immunization Schedule Influenza, Human/prevention & Control Influenza Vaccines Seasons
• Document Type:
  Webpage
• Collection(s):
  Advisory Committee on Immunization Practices (ACIP)
• Main Document Checksum:
  urn:sha-512:cb51473df72606067f5094292c8fe3dff9328d3a08c76e099bc06470ae0760adc13a7c71ec595bae5cf5abd4ac98057ff28e59968cdf689a9246f4b5d4c48da6
• Download URL:
  https://stacks.cdc.gov/view/cdc/133893/cdc_133893_DS1.pdf
• File Type:
  [PDF - 2.07 MB ]